A successful combination therapy of tacrolimus, hydroxychloroquine and picosecond laser for lichen planus pigmentosus

Wu, Chen‐Yu; Lin, Feng-Ling

doi:10.1111/ajd.13060

Cited by 10 publications

(6 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although these reports cast an optimistic outlook on the expanded use of picosecond lasers, further evidence is required in order to draw reliable conclusions. That being said, it is worthwhile noting that some traditionally difficult conditions to treat, such as minocycline-induced hyperpigmentation and chronic venous stasis hyperpigmentation have shown promising response and the use of picosecond laser in these settings should be considered an alternative treatment option when other modalities have proven unsatisfactory [30][31][32][33][34][35][36][37][38][39][41][42][43][44][45]94].…”

Section: Other Non-melasma Pigmented Conditionsmentioning

confidence: 99%

A Systematic Review of Picosecond Laser in Dermatology: Evidence and Recommendations

et al. 2020

View full text Add to dashboard Cite

Background and Objectives The use of picosecond laser in dermatology was originally focused on optimizing the removal of unwanted tattoos. Subsequent advances in this technology have broadened its clinical indications to include treatment of benign pigmented lesions, photodamage, melasma, and scar revision. In this systematic review, evidence‐based recommendations are developed for the use of picosecond laser in dermatology. Study Design/Materials and Methods A comprehensive search of the English language literature was performed up to and including November 2019. Relevant citations were individually evaluated, synthesized, and categorized based on the Level of Evidence. With the addition of the authors’ combined clinical experience, clinical recommendations were developed. Results After application of inclusion and exclusion criteria, a total of 77 unique studies were evaluated. Treatment of benign pigmented lesions was associated with level I–IV evidence; rejuvenation was associated with level II evidence; melasma was associated with level II evidence; scar revision was associated with level II–III evidence; tattoo removal was associated with level I evidence. Conclusion Picosecond laser is a safe and effective treatment modality for an increasing range of dermatologic indications. Further development of this technology is warranted. Lasers Surg. Med. © 2020 Wiley Periodicals, Inc.

show abstract

Section: Other Non-melasma Pigmented Conditionsmentioning

confidence: 99%

A Systematic Review of Picosecond Laser in Dermatology: Evidence and Recommendations

et al. 2020

View full text Add to dashboard Cite

show abstract

“…On the other hand, the treatment of other nonmelasma pigmentary lesions with PS laser was satisfactory. [44][45][46][47][48][49][50][51][52][53][54][55][56][57][58] Based on a systematic review, the level of evidence for the use of the PS laser for other pigmentary lesions was 4, 15 highlighting the need for high-quality research on the subject. As for the risk of PIH, it is high for darker skins.…”

Section: Discussionmentioning

confidence: 99%

“…In this meta‐analysis from Asian patients treated with a PS laser, the proportions of patients achieving excellent outcomes were higher for nevus of Ota and solar lentigines, consistent with the literature. On the other hand, the treatment of other nonmelasma pigmentary lesions with PS laser was satisfactory 44‐58 . Based on a systematic review, the level of evidence for the use of the PS laser for other pigmentary lesions was 4, 15 highlighting the need for high‐quality research on the subject.…”

Section: Discussionmentioning

confidence: 99%

Treatment of pigmentary disorders using picosecond laser in Asian patients: A meta‐analysis and systematic review

Dong

Wang

Yuan

et al. 2021

Dermatologic Therapy

View full text Add to dashboard Cite

There were many studies evaluating the effect of picosecond (PS) lasers, but no meta‐analysis examined the effects of PS laser in the treatment of pigmentary disorders in Asians. The aim of this article was to review the before‐after effect of PS laser in Asians for the treatment of pigmentary disorders. PubMed, Embase, and Cochrane library were searched for articles published up to May 2020. The evaluations were summarized into a 4‐point scale that ranged from <25% (poor), 25%‐50% (fair), 50%‐75% (good), and 75%‐100% (excellent). Effect sizes (ESs) were calculated according to laser wavelengths and lesion types. There were two randomized controlled trials, three single‐arm trials, and three case series, with 200 patients. At 3 months after treatment, of all included patients, 3% (95%CI: 1%‐6%) were evaluated as poor or worse, 9% (95%CI: 2%‐21%) as fair, 29% (95%CI: 12%‐50%) as good, and 56% (95%CI: 28%‐83%) as excellent. The 532 and 1064, and 755 nm PS lasers had similar ESs across all four response groups. This meta‐analysis suggested that 56% of Asian patients who underwent PS laser for the treatment of pigmentary disorders were evaluated as “excellent” about the pigment clearance by a dermatologist at least 3 months after treatment.

show abstract

“…This was then combined with laser to reduce the residual hyperpigmentation. [ 38 ] Among chemical peels, croton oil-free phenol combination peel every 3 weeks was found to reduce the pigmentation by up to 75%. [ 39 ] In our experience, patients are mostly dissatisfied with minimal if any response obtained after lasers and peels.…”

Section: Treatment Of Acquired Macular Pigmentation Disordersmentioning

confidence: 99%

Acquired Dermal Macular Hyperpigmentation

Vinay

Bishnoi

Kamat

et al. 2021

Indian Dermatology Online Journal

View full text Add to dashboard Cite

Acquired dermal macular hyperpigmentation (ADMH) is an umbrella term that includes disorders clinically characterized by small and large pigmented macules/patches and histopathologically showing an evidence of current or resolved interface dermatitis with pigment incontinence, without clinically significant prior inflammatory phase. The term intends to include diseases previously described in the literature as lichen planus pigmentosus, Riehl's melanosis/pigmented cosmetic dermatitis and ashy dermatosis/erythema dyschromicum perstans. The nomenclature and origin of these disorders have always been a matter of discussion. These disorders share many clinicopathological similarities, are difficult to treat and adversely affect the quality of life. Recent consensus points towards the need for a unifying term to facilitate research and therapeutic trials. This article aims to provide a comprehensive review of the recent advances in ADMH.

show abstract

A successful combination therapy of tacrolimus, hydroxychloroquine and picosecond laser for lichen planus pigmentosus

Cited by 10 publications

References 6 publications

A Systematic Review of Picosecond Laser in Dermatology: Evidence and Recommendations

A Systematic Review of Picosecond Laser in Dermatology: Evidence and Recommendations

Treatment of pigmentary disorders using picosecond laser in Asian patients: A meta‐analysis and systematic review

Acquired Dermal Macular Hyperpigmentation

Contact Info

Product

Resources

About